The chemical class referred to as AFAP1L2 Inhibitors comprises a diverse group of compounds that can modulate the activity of AFAP1L2, a protein integral to the regulation and organization of the actin cytoskeleton in cells. These inhibitors work by targeting various aspects of actin dynamics and associated cellular mechanisms, which are critical to AFAP1L2's function. The primary mode of action of these compounds is not a direct inhibition of the AFAP1L2 protein itself but an alteration of the cellular processes and pathways in which AFAP1L2 is involved. This includes influencing the polymerization and depolymerization of actin filaments, the formation of actin structures, and the interactions between actin and other cellular components. By modulating these processes, the compounds can alter the functional state of AFAP1L2, thereby influencing its role in the cell.
The effectiveness of these inhibitors lies in their ability to interact with key processes that govern the actin cytoskeleton. This includes the stabilization or destabilization of actin filaments, the regulation of actin-myosin interactions, and the modulation of signaling pathways that oversee actin filament assembly and disassembly. The actin cytoskeleton is a dynamic structure, constantly being remodeled in response to various cellular signals and mechanical forces. AFAP1L2 inhibitors can affect this remodeling process, thereby impacting the functions dependent on the actin cytoskeleton, such as cell shape maintenance, cell motility, and intracellular transport. By influencing the organization of the actin cytoskeleton, these inhibitors can also affect cellular processes like adhesion, migration, and mechanotransduction - the conversion of mechanical stimuli into chemical activity. The class of AFAP1L2 inhibitors thus represents a significant area of interest in the study of cellular dynamics and structure. Their diverse mechanisms of action reflect the complexity of targeting specific proteins and their associated cellular functions. These inhibitors highlight the intricate interplay between different cellular components and the potential of targeting such interactions to modulate protein activity. The ability to influence the actin cytoskeleton through these compounds provides valuable insights into the fundamental processes of cell biology and the regulation of critical cellular structures.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Disrupts actin filament polymerization and could possibly inhibit AFAP1L2 by affecting actin cytoskeleton dynamics. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Binds to actin monomers and prevents their polymerization, which could possibly inhibit AFAP1L2 by altering actin dynamics. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments and could possibly inhibit AFAP1L2 by modifying actin cytoskeleton structure. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK, which could possibly inhibit AFAP1L2 by affecting actin cytoskeleton remodeling. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Inhibits myosin II activity, which could possibly inhibit AFAP1L2 by impacting actin-myosin interactions. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Inhibits myosin light chain kinase, which could possibly inhibit AFAP1L2 by affecting actin dynamics. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
Inhibits Arp2/3 complex-mediated actin polymerization, which could possibly inhibit AFAP1L2's role in actin organization. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
Inhibits N-WASP, which could possibly inhibit AFAP1L2 by affecting actin cytoskeleton dynamics. | ||||||
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $234.00 | 33 | |
Stabilizes actin filaments, which could possibly inhibit AFAP1L2 by altering actin cytoskeleton dynamics. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Disrupts microtubule dynamics and could possibly inhibit AFAP1L2 by affecting overall cytoskeletal organization. | ||||||